AbbVie, Merck, and other pharma giants are reportedly set to announce major US drug price cuts this Friday. Following pressure from the Trump administration, these deals aim to lower costs for Medicaid and ensure new drug prices don't exceed those in other wealthy nations. With names like Novartis involved, this MFN deal marks a historic shift in US prescription market.